The Scotts Miracle-Gro Company (NYSE:SMG - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $61.98 and traded as low as $61.37. Scotts Miracle-Gro shares last traded at $61.4690, with a volume of 933,282 shares changing hands.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on SMG shares. UBS Group lifted their price objective on Scotts Miracle-Gro from $70.00 to $77.00 and gave the company a "buy" rating in a research report on Thursday, November 5th. Wall Street Zen lowered Scotts Miracle-Gro from a "buy" rating to a "hold" rating in a research note on Saturday, August 1st. Stifel Nicolaus cut their price target on Scotts Miracle-Gro from $76.00 to $75.00 and set a "buy" rating for the company in a report on Tuesday, September 29th. Weiss Ratings cut Scotts Miracle-Gro from a "hold (c)" rating to a "hold (c-)" rating in a report on Tuesday, October 6th. Finally, Wells Fargo & Company increased their price objective on shares of Scotts Miracle-Gro from $71.00 to $76.00 and gave the stock an "overweight" rating in a report on Thursday, November 5th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $74.80.
Read Our Latest Stock Analysis on Scotts Miracle-Gro
Scotts Miracle-Gro Stock Performance
The firm's fifty day simple moving average is $56.62 and its 200 day simple moving average is $61.98. The stock has a market capitalization of $3.58 billion, a price-to-earnings ratio of 36.59 and a beta of 1.87.
Scotts Miracle-Gro (NYSE:SMG - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The basic materials company reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.21) by $0.05. The company had revenue of $302.90 million during the quarter, compared to analysts' expectations of $306.11 million. Scotts Miracle-Gro had a negative return on equity of 77.42% and a net margin of 3.16%. Scotts Miracle-Gro's revenue for the quarter was down 10.9% compared to the same quarter last year. During the same period in the prior year, the firm earned ($2.63) earnings per share. Analysts forecast that The Scotts Miracle-Gro Company will post 4.78 earnings per share for the current year.
Scotts Miracle-Gro Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 4th. Shareholders of record on Friday, November 20th will be paid a $0.66 dividend. The ex-dividend date is Friday, November 20th. This represents a $2.64 dividend on an annualized basis and a yield of 4.3%. Scotts Miracle-Gro's dividend payout ratio (DPR) is currently 157.14%.
Insider Buying and Selling
In related news, Director Peter E. Shumlin sold 3,716 shares of the business's stock in a transaction on Friday, November 13th. The stock was sold at an average price of $64.51, for a total transaction of $239,719.16. Following the sale, the director owned 27,130 shares in the company, valued at $1,750,156.30. The trade was a 12.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director David C. Evans sold 2,655 shares of Scotts Miracle-Gro stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $66.42, for a total transaction of $176,345.10. Following the transaction, the director directly owned 25,405 shares in the company, valued at approximately $1,687,400.10. This represents a 9.46% decrease in their position. The SEC filing for this sale provides additional information. 24.40% of the stock is currently owned by insiders.
Institutional Trading of Scotts Miracle-Gro
A number of large investors have recently added to or reduced their stakes in the stock. Madison Asset Management LLC purchased a new stake in Scotts Miracle-Gro in the second quarter worth approximately $7,163,000. Royal Bank of Canada boosted its stake in Scotts Miracle-Gro by 182.2% in the 1st quarter. Royal Bank of Canada now owns 66,698 shares of the basic materials company's stock worth $4,057,000 after purchasing an additional 43,066 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new stake in Scotts Miracle-Gro during the 2nd quarter valued at about $1,323,000. Corient Private Wealth LP grew its position in Scotts Miracle-Gro by 500.3% during the 2nd quarter. Corient Private Wealth LP now owns 114,728 shares of the basic materials company's stock valued at $7,814,000 after purchasing an additional 95,616 shares during the last quarter. Finally, Bank of America Corp DE raised its holdings in Scotts Miracle-Gro by 16.4% in the first quarter. Bank of America Corp DE now owns 658,602 shares of the basic materials company's stock worth $40,050,000 after buying an additional 92,614 shares during the last quarter. Hedge funds and other institutional investors own 74.07% of the company's stock.
Scotts Miracle-Gro Company Profile
(
Get Free Report)
Scotts Miracle-Gro Company develops, manufactures and markets branded products for lawn care and gardening. Its offerings include grass seed, lawn fertilizers and weed-control products, soils, plant foods and other products for growing and maintaining lawns, gardens and landscapes. Its consumer brands include Scotts, Miracle-Gro and Ortho. The company also has a Hawthorne business that supplies equipment and products for indoor and hydroponic gardening. Scotts Miracle-Gro's products are sold primarily in North America, with additional operations and sales in international markets.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Scotts Miracle-Gro, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scotts Miracle-Gro wasn't on the list.
While Scotts Miracle-Gro currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.